Accuray’s Radixact image-guided radiotherapy gets FDA clearance

Accuray announced today that it has received FDA clearance for its Radixact Treatment Delivery Platform for radiotherapy. The hardware and software solutions that are part of the system, Treatment Planning System and iDMS Data Management System, allow for faster and more efficient delivery of treatment, and according to the announcement, will be able to treat a wider range of cancer patients — including those undergoing retreatment.
Dot Med